Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Maverick Therapeutics
company
About
Maverick Therapeutics is a biotech company focused on improving the lives of patients with solid tumor cancers
- 10001 - max
Details
- Last Funding Type
- Series Unknown
- Last Funding Money Raised
- $125M
- Industries
- Biotechnology
- Founded date
- Jan 1, 2016
- Number Of Employee
- 10001 - max
- Operating Status
- Active
Maverick Therapeutics is a biotech company focused on improving the lives of patients with solid tumor cancers by developing breakthrough T cell immunotherapies with improved safety and efficacy. Their highly innovative platform, COBRA™, is the most advanced bispecific T cell engaging platform in its class, designed to safely target solid tumors with highly specific and potent activity.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$125M
Maverick Therapeutics has raised a total of
$125M
in funding over 2 rounds. Their latest funding was raised on
Jan 1, 2017 from a Series Unknown round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jan 1, 2017 | Series Unknown | $125M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Maverick Therapeutics is funded by 1 investors.
Takeda
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Takeda
|
— | Series Unknown |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
